# Dexmedetomidine Premedication in Hypertensive Patients

Study · id `cardio:ct-nct02058485` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02058485](<https://clinicaltrials.gov/study/NCT02058485>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02058485

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.

## Technical summary

Registry record NCT02058485. Randomized; triple masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2013-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 162 participants (enrolled count; ClinicalTrials.gov record NCT02058485, source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT02058485, source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)
- Primary completion: 2013-04 (actual) (ClinicalTrials.gov record NCT02058485, source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)
- Completion: 2013-06 (actual) (ClinicalTrials.gov record NCT02058485, source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)
- Countries: Türkiye (ClinicalTrials.gov record NCT02058485, source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02058485-2014-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dexmedetomidine Premedication in Hypertensive Patients
- Condition: Hypertension
- Intervention (Drug): Midazolam
- Intervention (Drug): Dexmedetomidine
- Lead sponsor: Duzce University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Does premedication with dexmedetomidine provide perioperative hemodynamic stability in hypertensive patients? (`cardio:pubmed-25550680`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b655855a1ddf05b89f2b6b8626a13b38b7fbb66027bec54a0c9b7e2bf0c5bac0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
